Allspring Global Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Buy
10,039
+424
+4% +$106K ﹤0.01% 1026
2025
Q4
$2.35M Buy
9,615
+593
+7% +$152K ﹤0.01% 1000
2025
Q3
$2.44M Sell
9,022
-122
-1% -$33.3K ﹤0.01% 995
2025
Q2
$2.34M Buy
9,144
+2,286
+33% +$545K ﹤0.01% 1019
2025
Q1
$1.52M Sell
6,858
-6
-0.1% -$1.4K ﹤0.01% 1152
2024
Q4
$1.57M Sell
6,864
-343
-5% -$82.6K ﹤0.01% 1195
2024
Q3
$1.76M Buy
7,207
+9
+0.1% +$2.01K ﹤0.01% 1194
2024
Q2
$1.38M Sell
7,198
-26,829
-79% -$5.44M ﹤0.01% 1263
2024
Q1
$6.74M Buy
34,027
+8,311
+32% +$1.52M 0.01% 879
2023
Q4
$4.42M Sell
25,716
-1,996
-7% -$307K 0.01% 984
2023
Q3
$4.1M Sell
27,712
-1,062
-4% -$192K 0.01% 1021
2023
Q2
$6.29M Sell
28,774
-1,318
-4% -$294K 0.01% 937
2023
Q1
$6.59M Buy
30,092
+19,002
+171% +$4.12M 0.01% 916
2022
Q4
$2.31M Sell
11,090
-5,796
-34% -$1.27M ﹤0.01% 1200
2022
Q3
$3.69M Buy
16,886
+4,045
+32% +$921K 0.01% 1061
2022
Q2
$2.69M Sell
12,841
-24,108
-65% -$5.13M ﹤0.01% 1152
2022
Q1
$8.96M Sell
36,949
-932
-2% -$225K 0.01% 920
2021
Q4
$9.87M Buy
+37,881
New +$9.83M 0.01% 925

Other funds holding RMD

Allspring Global Investments's RMD Position: Q1 2026 in Review

Allspring Global Investments increased its ResMed (RMD) stake by 4.4% in Q1 2026, buying an estimated $106K and bringing the position to 10,039 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

Allspring Global Investments first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.87M in Q4 2021. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Allspring Global Investments held 10,039 shares of ResMed worth $2.24M as of Q1 2026.
  • Allspring Global Investments bought 424 ResMed shares in Q1 2026, an estimated $106K.
  • ResMed made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1026 holding.
  • Allspring Global Investments first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's ResMed position peaked at $9.87M in Q4 2021.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.